Advertisement Juvaris names new CEO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Juvaris names new CEO

Juvaris BioTherapeutics has appointed Grant Pickering as CEO, replacing Martin Cleary, who founded the company in February, 2003.

Mr Pickering will also be elected to the company’s board of directors. In conjunction with Mr Pickering’s appointment, the corporate headquarters will now be located within the company’s recently expanded research, development and manufacturing facilities in Burlingame, California.

Prior to joining Juvaris, Mr Pickering founded Pharmada, where he served as its president and CEO.